BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Noorik Biopharmaceuticals announces contract for ambrisentan treatment of COVID-19

Noorik Biopharmaceuticals Ltd. ("Noorik"), a clinical-stage biopharmaceutical company repurposing micro-dose ambrisentan for the treatment of kidney, liver...

December 16, 2021 | News

ARISTA Biotech Confirms Antigen Test Effectiveness Against Omicron and other COVID variants

On 26th November 2021, the World Health Organization (WHO) announced and designated variant B.1.1529 named Omicron, a newly identified variant first identi...

December 15, 2021 | News

HKU microbiology researchers collaborating with vaccine manufacturers

After successfully isolating the SARS-CoV-2 Omicron variant from clinical specimens, researchers at the Department of Microbiology at The University of Hon...

December 14, 2021 | News

Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant

South Korea’s leading molecular diagnostics company, today unveiled another series of diagnostic test that detects the ever-changing COVID-19 variant...

December 13, 2021 | News

Dotz Appoints Two New Distributors for Its RT-LAMP COVID-19 Diagnostics Solution in Southeast Asia

Leading scientific solution providers ScienceVision Sdn Bhd and World Siam Group Co., Ltd. (WSG) will promote, sell and distribute the Dotz Mega-Diagnostic...

December 10, 2021 | News

WHO Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the interim recommendation by the Strategic Advisory Group of Experts on Immunization ...

December 10, 2021 | News

FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds

"Vaccination and getting a booster when eligible, along with other preventive measures like masking and avoiding large crowds and poorly ventilated spaces,...

December 10, 2021 | News

Sino Biological newly launched a panel of research reagents for SARS-CoV-2 Omicron variant

Sino Biological's new Omicron product line includes recombinant Omicron Spike proteins (RBD, S1, and S-ECD trimer), monoclonal antibodies&nb...

December 08, 2021 | News

GSK Announces Additional Supply of Monoclonal Antibody Sotrovimab to the SIngapore Govt.

GSK Singapore is contracted to supply the Government of Singapore with additional doses of sotrovimab, following the first purchase placed by t...

December 07, 2021 | News

Seegene's PCR test combining numerous technologies to detect the new Omicron variant

Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, confirmed today that its Allplex™ SARS-CoV-2 Master test ...

December 06, 2021 | News

Mongolian Government To Build On COVID-19 Vaccine And Booster Success

Mongolia is preparing to build on the success of its COVID-19 management policies with an ambitious new budget and progressive initiatives as part of ...

December 06, 2021 | News

Acumen Diagnostics' PCR capabilities to tackle Omicron COVID-19 variant

PCR test kits able to detect COVID-19 positive cases including those infected with Omicron variant- Homegrown medical technology company that is fully inte...

December 03, 2021 | News

GenScript, BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan

BC-PIV, an innovative non-transmissible viral vector co-developed by BioComo and Mie University, is derived from the recombinant human parainfluenza virus ...

December 03, 2021 | News

Cue Health Receives Singapore HSA Authorization for its Molecular COVID-19 Test for Self-Testing

- The HSA authorization of the Cue COVID-19 Test is for home use in both symptomatic and asymptomatic users, ages 2 years and up - Cue Health has partnere...

December 02, 2021 | News

Stay Connected